CD274 and neoplasm: Predictive biomarkers for ICT response have been initially proposed as tumour-intrinsic factors, or as phenotyping immunohistochemistry biomarkers, such as programmed death-ligand 1 (PD-L1) expression on tumour and immune cells [65] and CD8+ TILs [66].